Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment.
Nat Commun. 2019 Dec 3;10(1):5499. doi: 10.1038/s41467-019-13329-5.
Nat Commun. 2019.
PMID: 31796750
Free PMC article.
ALICE: a randomized placebo-controlled phase II study evaluating atezolizumab combined with immunogenic chemotherapy in patients with metastatic triple-negative breast cancer.
Kyte JA, Røssevold A, Falk RS, Naume B.
Kyte JA, et al.
J Transl Med. 2020 Jun 23;18(1):252. doi: 10.1186/s12967-020-02424-7.
J Transl Med. 2020.
PMID: 32576225
Free PMC article.
Clinical Trial.
Item in Clipboard
Peripheral immune cells in metastatic breast cancer patients display a systemic immunosuppressed signature consistent with chronic inflammation.
Chauhan SK, Dunn C, Andresen NK, Røssevold AH, Skorstad G, Sike A, Gilje B, Raj SX, Huse K, Naume B, Kyte JA.
Chauhan SK, et al. Among authors: rossevold ah.
NPJ Breast Cancer. 2024 Apr 23;10(1):30. doi: 10.1038/s41523-024-00638-2.
NPJ Breast Cancer. 2024.
PMID: 38653982
Free PMC article.
Item in Clipboard
Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial.
Andresen NK, Røssevold AH, Quaghebeur C, Gilje B, Boge B, Gombos A, Falk RS, Mathiesen RR, Julsrud L, Garred Ø, Russnes HG, Lereim RR, Chauhan SK, Lingjærde OC, Dunn C, Naume B, Kyte JA.
Andresen NK, et al. Among authors: rossevold ah.
J Immunother Cancer. 2024 Jan 19;12(1):e007990. doi: 10.1136/jitc-2023-007990.
J Immunother Cancer. 2024.
PMID: 38242720
Free PMC article.
Clinical Trial.
Item in Clipboard
Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial.
Røssevold AH, Andresen NK, Bjerre CA, Gilje B, Jakobsen EH, Raj SX, Falk RS, Russnes HG, Jahr T, Mathiesen RR, Lømo J, Garred Ø, Chauhan SK, Lereim RR, Dunn C, Naume B, Kyte JA.
Røssevold AH, et al.
Nat Med. 2022 Dec;28(12):2573-2583. doi: 10.1038/s41591-022-02126-1. Epub 2022 Dec 8.
Nat Med. 2022.
PMID: 36482103
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite